Research Paper Volume 16, Issue 3 pp 2812—2827
Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer
Figure 4. Clinical significance of the risk model. (A, B) Patients with age >65 and age ≤65; (C, D) Female patients and male patients; (E, F) Patients with stages I–II and stages III–IV; (G, H) Patients with stages T1-2 and stages T3-4.